Identification of Novel Genetic Markers of Breast Cancer Survival
Qi Guo(Medical University of South Carolina), Carmel Apicella(The University of Melbourne), Jonathan P. Tyrer(University of Cambridge), Sander Canisius(University of Cambridge), Fergus J. Couch(Mayo Clinic), Karin Leunen(Fondazione IRCCS Istituto Nazionale dei Tumori), Jenny Chang‐Claude(Universität Hamburg), Helen Tsimiklis(The University of Melbourne), Annegien Broeks, Joe Dennis(University of Cambridge), Mikael Eriksson(Herlev Hospital), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Fredrick R. Schumacher(Harvard University), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Irene L. Andrulis(University of Toronto), Sofia Khan(University of Helsinki), Anna Marie Mulligan, Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Peter Kraft(National Cancer Institute), Constance Chen(Harvard University), Carl Blomqvist(University of Helsinki), Celine M. Vachon(Leiden University Medical Center), Caroline Weltens(KU Leuven), Dieter Flesch‐Janys, Petra Seibold(German Cancer Research Center), Rainer Fagerholm(358 (Finland)), Siddhartha Kar(University of Cambridge), Mitul Shah(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Anja Rudolph(Institut für Qualität im Management (Germany)), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Børge G. Nordestgaard(Gentofte Hospital), Janet E. Olson(Cornell University), Julia A. Knight, Taru Muranen(Karolinska Institutet), Qin Wang(University of Cambridge), Frans B.L. Hogervorst(The Netherlands Cancer Institute), Kristiina Aittomäki(University of Helsinki), Hatef Darabi, Christopher A. Haiman(University of Southern California), John L. Hopper(The University of Melbourne), Gord Glendon, Sune F. Nielsen(Herlev Hospital), Brian E. Henderson(Trinity College Dublin), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Marjanka K. Schmidt(University of Cambridge), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Michael Lush(University of Cambridge)
Cited by 244
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k